The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline products is the healthy approach for selecting a winner.
http://ift.tt/1Jt5vv4
http://ift.tt/1Jt5vv4
No comments:
Post a Comment